Gastroparesis is a central issue in the Trulicity and GLP-1 case, because it is one of the dangerous complications people are experiencing after taking those products
Gastroparesis caused by non-pharmacologic etiologies is indeed known to affect drug absorption [6, 7]
Compared with DPP-4 inhibitors, the lower rate of hyperkalemia was consistently observed across individual agents in the SGLT-2 inhibitor (canagliflozin, dapagliflozin, empagliflozin) and GLP-1 receptor agonist (dulaglutide, exenatide, liraglutide, semaglutide) classes
Vivancos PD, Wolff T, Markovic J, Pallard FV, Foyer CH (2010) A nuclear glutathione cycle within the cell cycle